How to improve quality of life in patients with acute leukemia and comorbid ischemic heart disease treated with anthracycline-based induction chemotherapy
Summary. Aim: To evaluate the quality of life (QoL) parameters in patients with acute leukemia (AL) during standard induction chemotherapy, depending on the presence of concomitant ischemic heart disease and to improve them by the prevention of anthracycline cardiotoxicity with L-arginine. Materials...
Saved in:
| Date: | 2023 |
|---|---|
| Main Authors: | Skrypnyk, I., Maslova, G., Lymanets, T., Gusachenko, I. |
| Format: | Article |
| Language: | English |
| Published: |
PH Akademperiodyka
2023
|
| Subjects: | |
| Online Access: | https://exp-oncology.com.ua/index.php/Exp/article/view/2019-4-14 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Experimental Oncology |
Institution
Experimental OncologySimilar Items
-
Assessment of trace elements in serum of acute lymphoblastic and myeloid leukemia patients
by: Valadbeigi, S., et al.
Published: (2023) -
Woman with Turner syndrome and her child with acute leukemia (a case report)
by: Kitsera, N., et al.
Published: (2023) -
L-arginine is an effective medication for prevention of endothelial dysfunction, a predictor of anthracycline cardiotoxicity in patients with acute leukemia
by: Skrypnyk, I., et al.
Published: (2017) -
Rapamycin-induced autophagy plays a pro-survival role by enhancing up-regulation of intracellular ferritin expression in acute lymphoblastic leukemia
by: Gong, Y., et al.
Published: (2023) -
Determination of the dependence between climatic factors and Covid-19 disease incidence
by: Mitryasova, Olena P., et al.
Published: (2021)